Maravai LifeSciences Holdings Inc.

Industry

  • Biotechnology
    • Antisense, Oligonucleotides
    • Synthesis Technologies, Production Processes
    • Drug Discovery Technologies
      • Genomics-Proteomics
  • Digital Health
    • Disease Management
  • Research, Analytical Equipment & Supplies
  • Services
  • In Vitro Diagnostics

Other Names/Subsidiaries

  • Alphazyme
  • Cygnus Technologies
  • Glen Research
  • Molecular Assemblies
  • TriLink Biotechnologies
  • Vector Laboratories
See more in Biomedtracker

Latest on Maravai LifeSciences Holdings Inc.

Pink Sheet

Risks For Pharma Industry Remain As BIO Shifts Course On BIOSECURE Act

 
• By Sarah Karlin-Smith

The Biotechnology Innovation Organization appeared to do a 180 degree turn on 13 March when its new President & CEO John Crowley announced the trade group’s support for the BIOSECURE Act, a bill that

Medtech Insight

Financing: 2020 Ends On A High Note For Medtech

 
• By Deanna Kamienski and Maureen Riordan

Fourth-quarter device financing reached $4.2bn, up from the previous quarter’s $3.3bn. The initial public offering category made up the most, accounting for $1.3bn, or 32%, of the Q4 total, followed b